JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool

  • 0Department of Biotechnology, Motilal Nehru National Institute of Technology-Allahabad, Prayagraj, Uttar Pradesh, India.
Frontiers in Molecular Biosciences +

|

May 1, 2024

|

May 1, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Early detection of ovarian cancer is crucial due to its aggressive nature. MicroRNAs (miRNAs) show promise as sensitive biomarkers for diagnosing and managing this gynecological cancer.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Ovarian cancer is a leading cause of death among gynecological malignancies, often diagnosed late due to subtle early symptoms.
  • Metastasis is a key factor in ovarian cancer's high mortality rate, necessitating improved diagnostic and therapeutic strategies.

Purpose Of The Study

  • To review current microRNA-based approaches for early ovarian cancer detection.
  • To discuss the role of microRNAs in ovarian cancer progression, prognosis, and therapy.
  • To explore microRNAs as potential oncogenes or tumor suppressor genes in ovarian cancer.

Main Methods

  • Literature review of microRNA research in ovarian cancer.
  • Analysis of current diagnostic and treatment strategies for ovarian cancer.
  • Examination of microRNA involvement in cancer cell biology.

Main Results

  • MicroRNAs are short non-coding RNA molecules with high specificity and sensitivity for biomarker development.
  • MicroRNAs play significant roles in ovarian cancer cell progression, invasion, apoptosis, epithelial-mesenchymal transition, and metastasis.
  • MicroRNAs are implicated in chemosensitivity, resistance, and overall disease therapy.

Conclusions

  • MicroRNAs hold significant potential as early diagnostic biomarkers for ovarian cancer.
  • Understanding microRNA functions is vital for optimizing treatment personalization and improving patient outcomes.
  • Further research into microRNA-based diagnostics and therapeutics is warranted for effective ovarian cancer management.

Keywords: